SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-21-001221
Filing Date
2021-03-30
Accepted
2021-03-30 08:00:43
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 zk2125824.htm F-3 273819
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 7104
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 9297
4 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4005
5 image0.jpg GRAPHIC 12196
6 image00001.jpg GRAPHIC 51275
7 image00004.jpg GRAPHIC 3335
  Complete submission text file 0001178913-21-001221.txt   387373
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: F-3 | Act: 33 | File No.: 333-254848 | Film No.: 21783688
SIC: 2834 Pharmaceutical Preparations